Ignite Creation Date:
2025-12-25 @ 4:33 AM
Ignite Modification Date:
2026-01-26 @ 6:15 PM
Study NCT ID:
NCT01698918
Status:
COMPLETED
Last Update Posted:
2023-05-03
First Post:
2012-10-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2015-12-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-13
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-01
First Submit QC Date:
None
Study First Post Date:
2012-10-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-01-12
Results First Submit QC Date:
None
Results First Post Date:
2022-02-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-28
Last Update Post Date:
2023-05-03
Last Update Post Date Type:
ACTUAL